From: A new relative tumor sizing method in epi-metaphyseal osteosarcoma
Mean ± SD | Interclass correlation (95% CI) | P | ||||
---|---|---|---|---|---|---|
Observer 1 | Observer 2 | Observer 3 | ||||
At diagnosis | RBS (mm) | 53.40 | 52.67 | 54.70 | 0.947 | <0.001 |
±24.38 | ±24.06 | ±24.49 | (0.905 to 0.972) | |||
ATL (mm) | 99.27 | 94.12 | 92.24 | 0.909 | <0.001 | |
±66.31 | ±67.84 | ±65.00 | (0.840 to 0.952) | |||
ATA (mm) | 49.23 | 55.74 | 41.24 | 0.725 | <0.001 | |
±20.93 | ±49.94 | ±16.19 | (0.509 to 0.855) | |||
TAR | 1.00 | 0.95 | 0.82 | 0.807 | <0.001 | |
±0.31 | ±0.36 | ±0.23 | (0.652 to 0.899) | |||
After Neoadjuvant Chemotherapy | RBS (mm) | 65.75 | 62.64 | 65.38 | 0.965 | <0.001 |
±20.84 | ±22.16 | ±21.02 | (0.942 to 0.979) | |||
ATL (mm) | 103.55 | 100.05 | 104.83 | 0.965 | <0.001 | |
±61.73 | ±63.58 | ±62.41 | (0.944 to 0.979) | |||
ATA (mm) | 50.18 | 53.24 | 46.91 | 0.775 | <0.001 | |
±17.64 | ±26.16 | ±17.49 | (0.640 to 0.865) | |||
TAR | 0.86 | 0.99 | 0.79 | 0.862 | <0.001 | |
±0.38 | ±0.50 | ±0.30 | (0.775 to 0.919) |